20 July, 2017 by The TZ Newswire Staff Comments Off on US toughens stance on foreign deals in blow to China’s buying spree
US toughens stance on foreign deals in blow to China’s buying spree
A secretive U.S. panel has objected to at least nine acquisitions of U.S. companies by foreign buyers this year, people familiar with the matter said.
20 July, 2017 by The TZ Newswire Staff Comments Off on These 3 Tech Leaders Are Within 2% Of Buy Points
These 3 Tech Leaders Are Within 2% Of Buy Points
Futures for the S&P 500, Nasdaq 100 and Dow Jones industrial average were little changed late Thursday even amid a flurry of big earnings releases, including Dow stocks Microsoft (MSFT) and Visa (V).
20 July, 2017 by The TZ Newswire Staff Comments Off on Government "Flabbergasted" After Elon Musk’s Most Bizarre Claim Yet
Government "Flabbergasted" After Elon Musk’s Most Bizarre Claim Yet
Elon Musk set the interwebs ablaze this morning when he tweeted out that he somehow got every major city on the eastern seaboard to “verbally approve” a “NY-Phil-Balt-DC Hyperloop” to be built by his Boring Company.
“Just received verbal govt approval for The Boring Company to build an underground NY-Phil-Balt-DC Hyperloop. NY-DC in 29 mins.”
“City center to city center in each case, with up to a dozen or more entry/exit elevators in each city.”
20 July, 2017 by The TZ Newswire Staff Comments Off on Polaris Industries Raises Guidance Despite a Tough Market
Polaris Industries Raises Guidance Despite a Tough Market
Polaris Industries Inc. (NYSE: PII) announced slightly better-than-expected second-quarter 2017 results on Thursday morning, thanks to broad-based improvements across the business, even with continued powersports market headwinds. Let’s take a deeper look at what the motorcycle and off-road vehicle (ORV) specialist accomplished in its latest quarter, as well as what investors can expect for the remainder of the year.
IMAGE SOURCE: POLARIS INDUSTRIES VIA BUSINESSWIRE.
Q2 2017
20 July, 2017 by The TZ Newswire Staff Comments Off on 3 Hottest Biotech Stocks of 2017 — Are They Still Buys Now?
3 Hottest Biotech Stocks of 2017 — Are They Still Buys Now?
Biotechnology’s top performing stocks this year have already given investors envy-inspiring returns, but there’s reason to believe that Calithera Biosciences (NASDAQ: CALA), Aurinia Pharmaceuticals (NASDAQ: AUPH), and Esperion Therapeutics (NASDAQ: ESPR) could still go higher. All three of these companies are run by proven winners, and each is developing drugs that target markets worth hundreds of millions of dollars, or more.
20 July, 2017 by The TZ Newswire Staff Comments Off on Dollar near two-year lows vs euro after Draghi comments
Dollar near two-year lows vs euro after Draghi comments
The dollar headed for weekly losses on Friday, wallowing at its lowest levels against the euro in nearly two years.
20 July, 2017 by The TZ Newswire Staff Comments Off on Strong earthquake of magnitude 6.7 strikes off Turkey coast, two reported killed in Greece
Strong earthquake of magnitude 6.7 strikes off Turkey coast, two reported killed in Greece
A powerful earthquake of magnitude 6.7 struck off the Aegean Turkish coast on Friday, the U.S. Geological Survey said.